resveratrol mouthwash for gingival hemorrhage

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Jan 2025: Trial started, NCT06882564
  2. 18 Mar 2025: Trial registered, NCT06882564

The trials

NCT06882564: Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.

State
Under way
Phase
Phase 3
People
54 planned
Started
5 Jan 2025
Primary completion
1 Apr 2025
Arms
Resveratrol group ( group A )
Results
None posted
  1. 5 Jan 2025: Trial started
  2. 18 Mar 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.